1. Academic Validation
  2. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA

Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA

  • Nanomedicine. 2017 May;13(4):1377-1387. doi: 10.1016/j.nano.2016.12.014.
Jayesh A Kulkarni 1 Johnathan Layne Myhre 2 Sam Chen 1 Yuen Yi C Tam 1 Adrian Danescu 2 Joy M Richman 2 Pieter R Cullis 3
Affiliations

Affiliations

  • 1 Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.
  • 2 Department of Oral Health Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • 3 Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: pieterc@mail.ubc.ca.
Abstract

Lipid nanoparticles (LNPs) containing distearoylphosphatidlycholine (DSPC), and ionizable amino-lipids such as dilinoleylmethyl-4-dimethylaminobutyrate (DLin-MC3-DMA) are potent siRNA delivery vehicles in vivo. Here we explore the utility of similar LNP systems as transfection reagents for plasmid DNA (pDNA). It is shown that replacement of DSPC by unsaturated PCs and DLin-MC3-DMA by the related lipid DLin-KC2-DMA resulted in highly potent transfection reagents for HeLa cells in vitro. Further, these formulations exhibited excellent transfection properties in a variety of mammalian cell lines and transfection efficiencies approaching 90% in primary cell cultures. These transfection levels were equal or greater than achieved by Lipofectamine, with much reduced toxicity. Finally, microinjection of LNP-eGFP into the limb bud of a chick embryo resulted in robust reporter-gene expression. It is concluded that LNP systems containing ionizable amino lipids can be highly effective, non-toxic pDNA delivery systems for gene expression both in vitro and in vivo.

Keywords

Gene delivery; Gene expression; Lipid nanoparticles; Nanomedicine; Plasmid.

Figures
Products